Winton Group LTD Harvard Bioscience Inc Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Winton Group LTD holds 54,559 shares of HBIO stock, worth $116,756. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,559

Previous 63,910 14.63%

Holding current value

$116,756

Previous $182,000 19.78%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.64 - $3.54 $24,686 - $33,102	-9,351 Reduced 14.63%	54,559 $146,000
Q2 2024 Aug 09, 2024	SELL	$2.77 - $4.63 $362 - $606	-131 Reduced 0.2%	63,910 $182,000
Q1 2024 May 14, 2024	SELL	$4.02 - $5.39 $385 - $517	-96 Reduced 0.15%	64,041 $271,000
Q4 2023 Feb 12, 2024	SELL	$4.0 - $5.49 $94,512 - $129,717	-23,628 Reduced 26.92%	64,137 $343,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $205,264 - $298,659	51,316 Added 140.79%	87,765 $377,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $152,721 - $224,525	36,449 New	36,449 $200,000
Q1 2022 May 11, 2022	SELL	$5.16 - $7.14 $63,034 - $87,222	-12,216 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$6.37 - $8.18 $321,309 - $412,607	-50,441 Reduced 80.5%	12,216 $86,000
Q3 2021 Oct 28, 2021	SELL	$6.98 - $8.47 $47,205 - $57,282	-6,763 Reduced 9.74%	62,657 $437,000
Q2 2021 Aug 10, 2021	SELL	$5.44 - $8.4 $3,361 - $5,191	-618 Reduced 0.88%	69,420 $578,000
Q1 2021 Jul 21, 2021	BUY	$3.91 - $6.99 $5,192 - $9,282	1,328 Added 1.93%	70,038 $382,000
Q4 2020 Feb 12, 2021	SELL	$3.0 - $4.5 $99,678 - $149,517	-33,226 Reduced 32.59%	68,710 $295,000
Q3 2020 Oct 30, 2020	SELL	$2.75 - $4.2 $81,075 - $123,824	-29,482 Reduced 22.43%	101,936 $307,000
Q2 2020 Aug 05, 2020	BUY	$2.12 - $3.14 $186,439 - $276,141	87,943 Added 202.28%	131,418 $407,000
Q1 2020 May 11, 2020	SELL	$1.42 - $3.29 $5,621 - $13,025	-3,959 Reduced 8.35%	43,475 $96,000
Q4 2019 Feb 13, 2020	BUY	$2.45 - $3.25 $2,582 - $3,425	1,054 Added 2.27%	47,434 $145,000
Q3 2019 Nov 08, 2019	BUY	$1.59 - $3.47 $73,744 - $160,938	46,380 New	46,380 $143,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account